[Home ] [Archive]   [ فارسی ]  
:: Main In Press Current Issue All Issues Search register ::
Main Menu
Home::
Journal Information::
Editorial Board::
Articles archive::
For Authors::
For Reviewers::
Editorial Policy::
Registration::
Contact us::
::
..
Indexing

 

 

 

 

 
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Creative commons

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

..
:: Search published articles ::
Showing 3 results for Colorectal Cancer

Farhad Pourfarzi, Abbas Yazdanbod, Reza Daneshvar , Seiyed Hosein Saberi ,
Volume 12, Issue 5 (11-2012)
Abstract

  Background & Objectives: Colorectal cancer is considered as the third prevalent malignancy worldwide. Investigation of information on cancers in Iran during 1985-1996 showed an increase in the incidence and prevalence of colorectal cancer. Its rank in Iran has increased from 9 to 5th during 10 years. It was reported as high prevalent cancer in Iranian people aged less than 40 years among Asian countries.

  Methods: In this cases-control study patients with a pathologic report of colorectal cancer were recruited among those cases registered in Ardabil Cancer Registry. Control group were selected from neighbors, frequency matched for age and gender. Subjects were interviewed using a questionnaire consisting information on age, gender, smoking, drugs and alcohol consuming, diet, family history of cancer and serum IgM and IgG level for H. pylori. Data were analyzed using SPSS v16.

  Results: In the current study, 43 persons (53.8%) were male and 37 (46.2%) were female. In the case group, 10 persons (12.5%) were under 40, 34 cases (42.5%) in age group of 41- 60 and 36 persons (45%) were more than 61 years. In the control group 12 persons (15%) were under 40, 36 persons (45.5%) in age group of 41-60 and 40 persons (68%) were more than 61 years. In the control group 3 cases had BMI less than 19, 36 cases (45%) between 19-24.9, 31 cases (38.8%) between 25-29.9 and 10 cases (12.5%) were more than 30, whereas this variable was 2.5, 32.5, 46.2 and 18.8% respectively in the case group.

  Positive history of smoking found to increase the risk of cancer around 1.8 times (OR= 1.78 CI: 0.91- 5.85). However, significant difference was not observed between two groups regarding alcoholic beverage consumption (p=0.385) . There were significant differences between two groups in terms of vegetables and carbohydrates intake. Difference was also significant between two groups regarding positive level of IgG. Among studied persons, 19 and 13 patients in case and control group had positive IgM respectively.

  Conclusion: Our finding showed an increased risk colorectal cancer in those consuming low vegetable and fruits and high carbohydrate consuming, having smoking history, positive family history of cancer and serum IgG level.


Shahla Mohammad Ganji , Mohammadnaser Molapour , Golamreza Javadi , Eisa Jahanzad,
Volume 16, Issue 3 (10-2016)
Abstract

Background & objectives: KAI1 is a tumor suppressor gene and inhibitor of metastasis in a wide range of malignancies. While it is ubiquitously expressed in normal tissues, KAI1 expression subjects to the down regulation in tumors. The present research aims semi-quantitative evaluation of KAI1 mRNA expression in Iranian patients with colorectal cancer (CRC) and correlation between expression levels of KAI1 and stage oftumorigenesis, especially metastasis and invasion of CRC as well as pathologic factors of patients.

Methods: RT-PCR was done by specific primers for KAI1 and β-actin genes on the 80 tumor tissues and 14 normal tissues as fresh samples which obtained from 80 unrelated patients referred to Imam Khomeini Hospital.  

Results: According the results, 51.2% and 48.8% of the sample were on and off for KAI1 gene expression, respectively. As a detail, 97.3% of samples in the stage 3 and 4 and 94.5% of metastatic phases samples showed no expression of this gene. Statistical analysis showed that there is a significant difference of the KAI1 expression between four groups of samples; normal, stage 1, 2 and 3 (p<0.05). Also a significant difference was observed between semi-quantitative KAI1 expression and degree of spread to regional lymph nodes (p=0.02) as well as semi-quantitative KAI1 expression and metastasis (p=0.000001).

Conclusion: A significant difference between semi-quantitative expression of KAI1 and degree of spread to regional lymph nodes (p=0.02) and metastasis (p=0.000001) was observed.


Behzad Baradaran, Saeed Noorolyai ,
Volume 18, Issue 4 (1-2018)
Abstract

 
Backgrounds & objectives: Colorectal cancer (CRC) is the third leading cause of cancer death worldwide. Micro RNAs are a group of non-coding small RNAs that inhibit the translation of target mRNA. MiR-146a-5p, as a tumor suppressor, has abnormal expression in many cancers. In this basic research, our goal was to restore the expression level of miR-146a-5p to normal level and to investigate its effect on the expression of the MMP9 gene in HT-29 cells.
Methods: this study evaluates the effect of transfection of miR-146a-5p in HT-29 cell line. At first, the HT-29 cell line from colorectal cancer was cultured in RPMI-1640 culture media and then  were transfected with miR-146a-5p using Jet-PEI reagent. qRT-PCR technique was employed to evaluate the expression level of miR-146a-5p and MMP9 genes. The statistical analysis was performed using GraphPad Prism 6 software.
Results: According to the obtained data, the onset of the invasion and metastasis, in particular, at the final stage of colorectal cancer may be related to a reduction in the expression of miR-146a-5p. The results of the qrRT-PCR test showed that by increasing the expression level of miR-146a-5p in HT-29 cells, the expression level of MMP9 gene decreased in the miR-146a-5p transfected group compared to the control group.
Conclusions: According to this study, activation of metastatic pathways was due to the down regulation of miR146a-5p. Accordingly, miR-146a-5p can inhibits migration of these cells through down-regulating the expression of metastasis-related genes. Hence, miR-146a-5p can be a new diagnostic biomarker and new therapeutic target for CRC.
 

Page 1 from 1     

مجله دانشگاه علوم پزشکی اردبیل Journal of Ardabil University of Medical Sciences
Persian site map - English site map - Created in 0.21 seconds with 31 queries by YEKTAWEB 4623